Close Menu

NEW YORK (GenomeWeb) – Cervical cancer screening using human papillomavirus (HPV) testing leads to significantly fewer high-grade cervical pathologies four years later than standard liquid-based cytology (LBC) screening, according to a randomized trial of approximately 19,000 Canadian women.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.